You are viewing: South Korea Synthetic Biology Market analysis
Part of: Synthetic Biology Market (Global)

The South Korea Synthetic Biology Market was valued at $35.9 Million in 2024 and projected to reach to $89.9 Million by 2029, representing a compound annual growth rate of 20.1%. South Korea's synthetic biology market is poised for significant expansion through 2029, driven by substantial government funding, world-class research institutions, and a thriving biotech ecosystem.

South Korea Synthetic Biology Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Synthetic Biology Market Trends and Insights

  • This expansion reflects South Korea's strong investment in biotechnology innovation and its position as a leading hub for advanced life sciences research in Asia Pacific.
  • South Korea's government support for synthetic biology initiatives and the presence of world-class research institutions are driving market acceleration. The synthetic biology sector in South Korea is benefiting from increasing demand for gene therapy, biomanufacturing, and personalized medicine solutions.
  • South Korea's pharmaceutical and biotech companies are actively developing synthetic biology applications across therapeutics and industrial biotechnology.
  • By 2029, South Korea is expected to solidify its role as a key player in the regional synthetic biology landscape, with continued investment in R&D and commercialization of synthetic biology-derived products..

Key Market Statistics

  • CAGR (2024-2029) 20.1% CAGR
  • Market Size, 2024 ~USD 35.9 Million
  • Forecast, 2029 ~USD 89.9 Million
  • Country South Korea

South Korea Synthetic Biology Market Overview

Market Valuation Growth :

South Korea's synthetic biology market is valued at $35.9 million in 2024, with projections reaching $89.9 million by 2029, representing a robust 20.1% CAGR over the forecast period.

Government Support & Innovation :

South Korea's government actively invests in synthetic biology initiatives, positioning the country as a leading biotechnology hub in Asia Pacific with strong policy frameworks supporting advanced life sciences research.

Regional Leadership :

As a key player in Asia Pacific's biotechnology landscape, South Korea leverages its technological expertise and research infrastructure to drive synthetic biology adoption across healthcare and industrial applications.

Competitive CAGR Performance :

With a 20.1% CAGR, South Korea's synthetic biology market growth closely aligns with the global rate of 20.6%, demonstrating strong market momentum and investor confidence in the sector.

South Korea Synthetic Biology Market Dynamics

  • The country's strategic focus on precision medicine, industrial biotechnology, and genetic engineering applications positions it as a critical innovation center in Asia Pacific.
  • South Korea's skilled workforce, advanced manufacturing capabilities, and collaborative research environment create favorable conditions for synthetic biology companies and startups.
  • Continued investment in R&D infrastructure and regulatory frameworks supporting biotechnology commercialization will further accelerate market growth, attracting both domestic and international players to establish operations and partnerships within the region..

Market Ecosystem

logo-mobile

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • South Korea's synthetic biology market is valued at $35.9 million in 2024 and is forecast to reach $89.9 million by 2029, representing a 20.1% CAGR.
      • South Korea's government initiatives and robust biotech ecosystem are accelerating synthetic biology adoption across gene therapy and biomanufacturing sectors.
      • South Korea's position in Asia Pacific is strengthened by its advanced research infrastructure and pharmaceutical industry collaboration in synthetic biology development.
      • South Korea's market growth is driven by increasing demand for personalized medicine and industrial biotechnology applications through 2029.

      Synthetic Biology Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment GENOME ENGINEERING (Technology)
      Forecast Period 2024-2029
      Growth Rate CAGR of 20.6% from 2024 to 2029
      Largest Segment MEDICAL APPLICATIONS (Application)
      Market Size Base Year (Billions) ~USD 12.36 (2024)
      Revenue Forecast (Billions) ~USD 31.52 (2029)
      Segments Covered Tool, Technology, Application, Type, Industry

      South Korea Synthetic Biology Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Tool

      • Chassis Organisms
      • Cloning Technology Kits
      • Enzymes
      • Oligonucleotides & Synthetic Dna
      • Synthetic Cells
      • Xeno Nucleic Acids

      By Technology

      • Bioinformatics
      • Cloning
      • Gene Synthesis
      • Genome Engineering
      • Measurement & Modeling
      • Microfluidics
      • Nanotechnology
      • Sequencing
      • Site-Directed Mutagenesis

      By Application

      • Environmental Applications
      • Food, Animal Health, And Agricultural Applications
      • Industrial Applications
      • Medical Applications

      By Type

      • Artificial Tissue & Tissue Regeneration
      • Biofuel & Renewable Energy
      • Biofuels & Renewable Energy
      • Biomaterials & Green Chemicals
      • Bioremediation
      • Biosensing
      • Biosynthesis
      • Cancer Detection & Diagnostics
      • Drug Discovery & Therapeutics
      • Flavors & Fragrances
      • Industrial Enzymes
      • Other Artificial Tissue & Tissue Regeneration Applications
      • Other Consumer Care Products
      • Other Drug Discovery & Therapeutic Applications
      • Other Food, Animal Health, And Agricultural Applications
      • Pharmaceuticals
      • Skincare & Cosmetics
      • Stem Cell Regulation

      By Industry

      • Consumer Care Industry
      • Other Industries
      • Paper Industry
      • Textile Industry

      Target Audience

      • Biotech Companies & Startups : South Korea-focused biotech firms need detailed market intelligence to benchmark performance, identify growth opportunities, and optimize product positioning within the competitive landscape.
      • Investment & Venture Capital Firms : Investors targeting South Korea's synthetic biology sector require comprehensive market data, growth forecasts, and risk assessments to make informed funding and portfolio decisions.
      • Pharmaceutical & Healthcare Corporations : Large pharma companies seeking to expand synthetic biology capabilities in South Korea need market insights, regulatory guidance, and partnership opportunities to strengthen regional presence.
      • Government & Policy Makers : South Korean government agencies and policymakers require market analysis to evaluate synthetic biology sector performance, guide funding allocation, and refine supportive regulatory policies.
      • Research Institutions & Universities : Academic and research organizations need market data to align research initiatives with commercial opportunities, secure funding, and establish industry partnerships in South Korea's biotech ecosystem.

      Reasons to Buy this Report

      • Market Size & Growth Trajectory : Gain precise valuation data for South Korea's synthetic biology market with detailed forecasts through 2029, enabling accurate investment planning and resource allocation decisions.
      • Regional Competitive Intelligence : Understand South Korea's market position relative to global trends and identify competitive advantages in Asia Pacific's synthetic biology landscape for strategic market entry.
      • Government Policy & Regulatory Insights : Access comprehensive analysis of South Korea's government support mechanisms, funding initiatives, and regulatory frameworks driving synthetic biology commercialization and innovation.
      • Investment & Partnership Opportunities : Identify high-growth segments, emerging players, and collaboration opportunities within South Korea's biotech ecosystem to maximize ROI and market penetration strategies.
      • Sector-Specific Application Analysis : Explore South Korea's synthetic biology applications across healthcare, industrial biotechnology, and precision medicine to align product development with market demand.

      Frequently asked questions

      What is the current size of South Korea's synthetic biology market?

      South Korea's synthetic biology market was valued at $35.9 million in 2024 and is expected to grow to $89.9 million by 2029.

      What is the projected growth rate for South Korea's synthetic biology market?

      South Korea's synthetic biology market is projected to grow at a compound annual growth rate (CAGR) of 20.1% from 2024 to 2029.

      What are the main drivers of growth in South Korea's synthetic biology market?

      South Korea's market growth is driven by government support for biotech innovation, increasing demand for gene therapy and personalized medicine, and strong pharmaceutical industry investment in synthetic biology applications.

      Which sectors are leading South Korea's synthetic biology market expansion?

      Gene therapy, biomanufacturing, and personalized medicine are the primary sectors driving South Korea's synthetic biology market growth through 2029.

      How does South Korea's synthetic biology market compare regionally?

      South Korea is positioned as a key player in the Asia Pacific synthetic biology market, supported by advanced research infrastructure, government backing, and a strong pharmaceutical and biotech industry ecosystem.

      RESEARCH METHODOLOGY

      The research study involved the wide use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global synthetic biology market. Extensive interviews were conducted with various primary participants, including key industry members, subject-matter experts (SMEs), C-level managers of leading market players, and industry consultants, to obtain and verify qualitative and quantitative information and evaluate the growth scenarios of the market. The global market size is estimated through secondary research (top-down and bottom-up) followed by data triangulation with inputs from industry experts to arrive at the final market size.

      Secondary Research

      Secondary research was used mainly to identify and collect information for the technical, market-oriented, and commercial study of the synthetic biology market. The secondary sources used for this study include World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), Lens.org, National Center for Biotechnology Information (NCBI), Imperial College Centre for Synthetic Biology, Institute of Systems & Synthetic Biology (iSSB), University of California San Francisco (UCSF), Center for Systems and Synthetic Biology, Synthetic Biology Leadership Council (SBLC), Engineering Biology Advisory Committee, Synthetic Biology Engineering Research Center (SynBERC), Biotechnology and Biological Sciences Research Council (BBSRC), Helmholtz Association of German Research Centres, Asian Synthetic Biology Association, World Bank, Academic Journals and Company Websites, corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations among others. These secondary sources were also used to obtain major information about key market players, and market segmentation corresponding to industry trends, regional/country-level markets, market developments, and technology prospects. Secondary data was collected and analysed to arrive at the market size of the global synthetic biology market, which was further validated through primary research.

      Primary Research

      Extensive primary research was conducted after acquiring basic knowledge about the global synthetic biology market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical & biopharmaceutical industries from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. The primary interviews were conducted across six major regions, including the North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

      The following is a breakdown of the primary respondents:

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the synthetic biology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      Data Triangulation

      After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Synthetic biology involves the redesign of natural biological systems by engineering and designing new biological parts and functions, namely synthetic biological pathways and organisms, which are used to construct end products. It is an innovative research area broadly comprising of multiple disciplines, such as biotechnology, molecular biology, genetic engineering, and biophysics, among others.

      Stakeholders

      • Companies Providing Synthetic Biology Tools, Technologies, and Related Products & Services
      • Research Institutes and Academic Centers
      • Suppliers and Distributors of Synthetic Biology Tools & Technologies
      • Pharmaceutical and Biotechnology Companies
      • Agricultural and Veterinary companies
      • Business Research and Consulting Service Providers
      • Venture Capitalists
      • Contract Research Organizations and Contract Development Manufacturing Organizations
      • Market research and consulting firms

      Report Objectives

      • To define, describe, and forecast the synthetic biology market by value by tool, technology, application, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall Synthetic biology market
      • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, Middle East and Africa
      • To profile the key players and analyze their market shares and core competencies2
      • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
      • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

      Get the Full Synthetic Biology Market Report

      Full forecast, segment splits, and company analysis for all Synthetic Biology Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status